Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Chemical & Pharmaceutical Bulletin
|
March 10, 2015
Characterization of a riboflavin non-aqueous nanosuspension prepared by bead milling for cutaneous application
Takayuki Sato, Hiroyuki Takeuchi, Takanobu Sakurai, et al.
Journal of Atherosclerosis and Thrombosis
|
February 14, 2008
HMG-CoA reductase inhibitor, simvastatin improves reverse cholesterol transport in type 2 diabetic patients with hyperlipidemia
Jing-Zhi Guan, Naoki Tamasawa, Hiroshi Murakami, et al.
Atherosclerosis
|
April 21, 2009
Metformin restores impaired HDL-mediated cholesterol efflux due to glycation
Kota Matsuki, Naoki Tamasawa, Maki Yamashita, et al.
Diabetes Research and Clinical Practice
|
November 10, 2012
Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes
Hiroshi Murakami, Jutaro Tanabe, Naoki Tamasawa, et al.
Atherosclerosis
|
March 30, 2025
Association of Achilles tendon thickness with lipid profile and carotid IMT in patients with familial hypercholesterolemia
Masahito Michikura, Masatsune Ogura, Mika Hori, et al.
Journal of Atherosclerosis and Thrombosis
|
January 22, 2023
Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022
Mariko Harada-Shiba, Akira Ohtake, Daisuke Sugiyama, et al.
Journal of Atherosclerosis and Thrombosis
|
June 16, 2016
Clinical Significance of Determining Plasma MicroRNA33b in Type 2 Diabetic Patients with Dyslipidemia
Yuki Kimura, Naoki Tamasawa, Koki Matsumura, et al.
Journal of Clinical Lipidology
|
January 24, 2012
Reduced cellular cholesterol efflux and low plasma high-density lipoprotein cholesterol in a patient with type B Niemann-Pick disease because of a novel SMPD-1 mutation
Naoki Tamasawa, Shinobu Takayasu, Hiroshi Murakami, et al.
Endocrine Journal
|
January 21, 2010
The frequency of type 2 diabetic patients who meet the endocrinological screening criteria of subclinical Cushing's disease
Hiroshi Murakami, Takeshi Nigawara, Satoru Sakihara, et al.
Journal of Atherosclerosis and Thrombosis
|
May 17, 2021
Current Diagnosis and Management of Tangier Disease
Masahiro Koseki, Shizuya Yamashita, Masatsune Ogura, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Chemical & Pharmaceutical Bulletin
|
March 10, 2015
Characterization of a riboflavin non-aqueous nanosuspension prepared by bead milling for cutaneous application
Takayuki Sato, Hiroyuki Takeuchi, Takanobu Sakurai, et al.
Journal of Atherosclerosis and Thrombosis
|
February 14, 2008
HMG-CoA reductase inhibitor, simvastatin improves reverse cholesterol transport in type 2 diabetic patients with hyperlipidemia
Jing-Zhi Guan, Naoki Tamasawa, Hiroshi Murakami, et al.
Atherosclerosis
|
April 21, 2009
Metformin restores impaired HDL-mediated cholesterol efflux due to glycation
Kota Matsuki, Naoki Tamasawa, Maki Yamashita, et al.
Diabetes Research and Clinical Practice
|
November 10, 2012
Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes
Hiroshi Murakami, Jutaro Tanabe, Naoki Tamasawa, et al.
Atherosclerosis
|
March 30, 2025
Association of Achilles tendon thickness with lipid profile and carotid IMT in patients with familial hypercholesterolemia
Masahito Michikura, Masatsune Ogura, Mika Hori, et al.
Journal of Atherosclerosis and Thrombosis
|
January 22, 2023
Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022
Mariko Harada-Shiba, Akira Ohtake, Daisuke Sugiyama, et al.
Journal of Atherosclerosis and Thrombosis
|
June 16, 2016
Clinical Significance of Determining Plasma MicroRNA33b in Type 2 Diabetic Patients with Dyslipidemia
Yuki Kimura, Naoki Tamasawa, Koki Matsumura, et al.
Journal of Clinical Lipidology
|
January 24, 2012
Reduced cellular cholesterol efflux and low plasma high-density lipoprotein cholesterol in a patient with type B Niemann-Pick disease because of a novel SMPD-1 mutation
Naoki Tamasawa, Shinobu Takayasu, Hiroshi Murakami, et al.
Endocrine Journal
|
January 21, 2010
The frequency of type 2 diabetic patients who meet the endocrinological screening criteria of subclinical Cushing's disease
Hiroshi Murakami, Takeshi Nigawara, Satoru Sakihara, et al.
Journal of Atherosclerosis and Thrombosis
|
May 17, 2021
Current Diagnosis and Management of Tangier Disease
Masahiro Koseki, Shizuya Yamashita, Masatsune Ogura, et al.
Page
of 4